phone icon(716) 674-6030 fax icon(716) 674-6052
bill pay iconPay Your Bill
Receive our Health e-Newsletter
  Home  
  Our Team  
  Patient Info  
  Services  
   
  Patient Info  

News for Healthier Living

Gut, Airway and Tumor Microbes Emerge as Promising Predictors of Immunotherapy Response in Lung Cancer

Only 20% to 40% of patients with non small cell lung cancer (NSCLC) respond to immune checkpoint inhibitors, leaving the majority without meaningful clinical benefit. Current biomarkers such as programmed death ligand 1 (PD L1) expression and tumor mutational burden have limited predictive accuracy.

September 9, 2026


September 18 2026

September 17 2026

September 16 2026

September 15 2026

September 14 2026

September 11 2026

September 10 2026

September 9 2026

September 8 2026

September 7 2026

September 5 2026

September 4 2026